Parkin is not required to sustain OXPHOS function in adult mammalian tissues

• DOI: 10.1101/2023.09.02.556020
• Publication Date: 2023-09-03T07:55:14Z
• Authors: Roberta Filograna; Jule Gerlach; Hae-Na Choi; Giovanni Rigoni; Michela Barbaro; Mikael Oscarson; Seungmin Lee; Katarina Tiklova; Markus Ringnér; Camilla Koolmeister; Rolf Wibom; Sara Riggare; Inger Nennesmo; Thomas Perlmann; Anna Wredenberg; Anna Wedell; Elisa Motori; Per Svenningsson; Nils-Göran Larsson
• Keywords: 0303 health sciences; 03 medical and health sciences; Neurosciences; Neurology. Diseases of the nervous system; RC346-429; Neurovetenskaper; Article

AbstractLoss-of-function variants in thePRKNgene encoding the ubiquitin E3 ligase PARKIN cause autosomal recessive early-onset Parkinson’s disease (PD). Extensivein vitroandin vivostudies have reported that PARKIN is involved in multiple pathways of mitochondrial quality control, including mitochondrial degradation and biogenesis. However, these findings are surrounded by substantial controversy due to conflicting experimental data. In addition, the existing PARKIN-deficient mouse models have failed to faithfully recapitulate PD phenotypes. Therefore, we have investigated the mitochondrial role of PARKIN during ageing and in response to stress by employing a series of conditionalParkinknockout mice. We report that PARKIN loss does not affect oxidative phosphorylation (OXPHOS) capacity and mitochondrial DNA (mtDNA) levels in the brain, heart, and skeletal muscle of aged mice. We also demonstrate that PARKIN deficiency does not exacerbate the brain defects and the pro-inflammatory phenotype observed in mice carrying high levels of mtDNA mutations. To rule out compensatory mechanisms activated during embryonic development ofParkin-deficient mice, we generated a mouse model where loss of PARKIN was induced in adult dopaminergic (DA) neurons. Surprisingly, also these mice did not show motor impairment or neurodegeneration, and no major transcriptional changes were found in isolated midbrain DA neurons. Finally, we report a patient with compound heterozygousPRKNpathogenic variants that lacks PARKIN and has developed PD. The PARKIN deficiency did not impair OXPHOS activities or induce mitochondrial pathology in skeletal muscle from the patient. Altogether, our results argue that PARKIN is dispensable for OXPHOS function in adult mammalian tissues.